Neuroendocrine control of food intake.

PubWeight™: 2.21‹?› | Rank: Top 2%

🔗 View Article (PMID 18061414)

Published in Nutr Metab Cardiovasc Dis on December 03, 2007

Authors

Elena Valassi1, Massimo Scacchi, Francesco Cavagnini

Author Affiliations

1: Chair of Endocrinology, University of Milan, Ospedale San Luca IRCCS, Istituto Auxologico Italiano, Via Spagnoletto 3, 20149 Milan, Italy.

Associated clinical trials:

Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity. | NCT01008371

Articles citing this

Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab (2012) 2.78

Stress-induced obesity and the emotional nervous system. Trends Endocrinol Metab (2009) 2.25

A fructose receptor functions as a nutrient sensor in the Drosophila brain. Cell (2012) 2.03

Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol (2008) 1.83

Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther (2011) 1.52

Leptin in human physiology and therapeutics. Front Neuroendocrinol (2010) 1.46

Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A (2009) 1.44

Control of Polyamine Biosynthesis by Antizyme Inhibitor 1 Is Important for Transcriptional Regulation of Arginine Vasopressin in the Male Rat Hypothalamus. Endocrinology (2015) 1.40

Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13

Influence of photoperiod on hormones, behavior, and immune function. Front Neuroendocrinol (2010) 1.04

Oxytocin, feeding, and satiety. Front Endocrinol (Lausanne) (2013) 1.03

Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology (2012) 1.03

Peptides and food intake. Front Endocrinol (Lausanne) (2014) 1.01

Hypothalamic glucose sensing: making ends meet. Front Syst Neurosci (2014) 1.01

Comparative Neuropeptidomic Analysis of Food Intake via a Multi-faceted Mass Spectrometric Approach. ACS Chem Neurosci (2010) 1.01

Wheel running eliminates high-fat preference and enhances leptin signaling in the ventral tegmental area. Physiol Behav (2010) 1.01

Development of a sleeve gastrectomy weight loss model in obese Zucker rats. J Surg Res (2008) 0.99

In vivo discharge properties of hypothalamic paraventricular nucleus neurons with axonal projections to the rostral ventrolateral medulla. J Neurophysiol (2009) 0.99

Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut (2014) 0.98

Brain regulation of energy balance and body weight. Rev Endocr Metab Disord (2013) 0.96

Dietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tract. Nutrients (2011) 0.95

Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle (2015) 0.93

New central targets for the treatment of obesity. Br J Clin Pharmacol (2009) 0.93

Corticotropin-releasing factor-overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting. Endocrinology (2008) 0.91

Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats. Nutr Metab (Lond) (2010) 0.90

Nutrient sensors. Curr Biol (2013) 0.90

Novel aspects of glucocorticoid actions. J Neuroendocrinol (2014) 0.89

Brain expression and song regulation of the cholecystokinin gene in the zebra finch (Taeniopygia guttata). J Comp Neurol (2011) 0.89

Ankyrin repeat and SOCS box containing protein 4 (Asb-4) colocalizes with insulin receptor substrate 4 (IRS4) in the hypothalamic neurons and mediates IRS4 degradation. BMC Neurosci (2011) 0.89

Ketosis, ketogenic diet and food intake control: a complex relationship. Front Psychol (2015) 0.89

Obesity: pathophysiology and intervention. Nutrients (2014) 0.88

Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88

PACAP in the BNST produces anorexia and weight loss in male and female rats. Neuropsychopharmacology (2014) 0.87

Isolating neural correlates of the pacemaker for food anticipation. PLoS One (2012) 0.86

Central pathways integrating metabolism and reproduction in teleosts. Front Endocrinol (Lausanne) (2014) 0.85

3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice. Br J Pharmacol (2012) 0.85

Lack of cAMP-response element-binding protein 1 in the hypothalamus causes obesity. J Biol Chem (2011) 0.85

Ghrelin receptor regulates appetite and satiety during aging in mice by regulating meal frequency and portion size but not total food intake. J Nutr (2014) 0.85

Electroacupuncture regulates glucose-inhibited neurons in treatment of simple obesity. Neural Regen Res (2013) 0.84

A Brief Review on How Pregnancy and Sex Hormones Interfere with Taste and Food Intake. Chemosens Percept (2009) 0.84

Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists. J Endocrinol (2010) 0.84

Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S. Front Physiol (2014) 0.83

Impact of maternal prenatal stress on growth of the offspring. Aging Dis (2013) 0.83

Myoinhibitory peptide regulates feeding in the marine annelid Platynereis. Front Zool (2015) 0.82

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci (2013) 0.82

Tweaking energy metabolism to prevent and treat neurological disorders. Clin Pharmacol Ther (2010) 0.82

Repeated gastric distension alters food intake and neuroendocrine profiles in rats. Physiol Behav (2011) 0.81

Controversies surrounding high-protein diet intake: satiating effect and kidney and bone health. Adv Nutr (2015) 0.81

Nesfatin-1/NUCB2 as a potential new element of sleep regulation in rats. PLoS One (2013) 0.81

Differences in brain responses between lean and obese women to a sweetened drink. Neurogastroenterol Motil (2013) 0.81

The role of psychobiological and neuroendocrine mechanisms in appetite regulation and obesity. Open Cardiovasc Med J (2012) 0.81

Regulation of hypothalamic neuropeptides gene expression in diet induced obesity resistant rats: possible targets for obesity prediction? Front Neurosci (2015) 0.81

Involvement of the neutral amino acid transporter SLC6A15 and leucine in obesity-related phenotypes. PLoS One (2013) 0.80

Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers. Psychoneuroendocrinology (2014) 0.80

Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects. Peptides (2009) 0.80

Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. Schizophr Res Treatment (2010) 0.79

Thyroid transcription factor-1 regulates feeding behavior via melanocortin pathway in the hypothalamus. Diabetes (2011) 0.79

The Brain-to-Pancreatic Islet Neuronal Map Reveals Differential Glucose Regulation From Distinct Hypothalamic Regions. Diabetes (2016) 0.79

Transcriptome analysis of the Trachinotus ovatus: identification of reproduction, growth and immune-related genes and microsatellite markers. PLoS One (2014) 0.78

Comparison of anorectic and emetic potencies of deoxynivalenol (vomitoxin) to the plant metabolite deoxynivalenol-3-glucoside and synthetic deoxynivalenol derivatives EN139528 and EN139544. Toxicol Sci (2014) 0.78

A novel form of ciliopathy underlies hyperphagia and obesity in Ankrd26 knockout mice. Brain Struct Funct (2014) 0.78

Ghrelin O-Acyl Transferase in Zebrafish Is an Evolutionarily Conserved Peptide Upregulated During Calorie Restriction. Zebrafish (2015) 0.78

Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome. J Transl Med (2016) 0.77

A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction. Evid Based Complement Alternat Med (2015) 0.77

Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake. EMBO Mol Med (2016) 0.77

Possible Role of GnIH as a Mediator between Adiposity and Impaired Testicular Function. Front Endocrinol (Lausanne) (2016) 0.77

Hyperphagia and leptin resistance in tissue inhibitor of metalloproteinase-2 deficient mice. J Neuroendocrinol (2011) 0.77

The effect of fasting and refeeding on mRNA expression of PepT1 and gastrointestinal hormones regulating digestion and food intake in zebrafish (Danio rerio). Fish Physiol Biochem (2012) 0.77

Effect of procainization of ventromedial nucleus of hypothalamus on the feeding behavior of rats. J Clin Biochem Nutr (2009) 0.77

Molecular characterization of cholecystokinin in grass carp (Ctenopharyngodon idellus): cloning, localization, developmental profile, and effect of fasting and refeeding on expression in the brain and intestine. Fish Physiol Biochem (2012) 0.77

Melatonin and peripheral circuitries: insights on appetite and metabolism in Danio rerio. Zebrafish (2013) 0.76

Food intake inhibition in rainbow trout induced by activation of serotonin 5-HT2C receptors is associated with increases in POMC, CART and CRF mRNA abundance in hypothalamus. J Comp Physiol B (2016) 0.76

Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling. J Cachexia Sarcopenia Muscle (2015) 0.76

Searching for the relationship between the parameters of metabolic syndrome and the rs17782313 (T>C) polymorphism of the MC4R gene in postmenopausal women. Clin Interv Aging (2017) 0.75

Peptides from adipose tissue in mental disorders. World J Psychiatry (2014) 0.75

Molecular regulation of hypothalamic development and physiological functions. Mol Neurobiol (2015) 0.75

Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis. J Diabetes Res (2014) 0.75

Desipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells. PLoS One (2012) 0.75

Food intake and appetite control in a GH-transgenic zebrafish. Fish Physiol Biochem (2015) 0.75

Programmed hyperphagia in offspring of obese dams: Altered expression of hypothalamic nutrient sensors, neurogenic factors and epigenetic modulators. Appetite (2016) 0.75

Correlations of circulating peptide YY and ghrelin with body weight, rate of weight gain, and time required to achieve the recommended daily intake in preterm infants. Braz J Med Biol Res (2012) 0.75

The Effect of Exercise Intensity on Total PYY and GLP-1 in Healthy Females: A Pilot Study. J Nutr Metab (2017) 0.75

Role of gastrointestinal hormones in feeding behavior and obesity treatment. J Gastroenterol (2015) 0.75

Age-related changes in central effects of corticotropin-releasing factor (CRF) suggest a role for this mediator in aging anorexia and cachexia. Geroscience (2017) 0.75

An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways. Mol Cell Proteomics (2017) 0.75

Differential effects of hunger and satiety on insular cortex and hypothalamic functional connectivity. Eur J Neurosci (2016) 0.75

Appetite-Controlling Endocrine Systems in Teleosts. Front Endocrinol (Lausanne) (2017) 0.75

Comparison of Anorectic Potencies of the Trichothecenes T-2 Toxin, HT-2 Toxin and Satratoxin G to the Ipecac Alkaloid Emetine. Toxicol Rep (2015) 0.75

Oxytocin decreases sweet taste sensitivity in mice. Physiol Behav (2014) 0.75

Ghrelin affects stopover decisions and food intake in a long-distance migrant. Proc Natl Acad Sci U S A (2017) 0.75

Severe obesity, emotions and eating habits: a case-control study. BMC Obes (2017) 0.75

Loss of Mrap2 is associated with Sim1 deficiency and increased circulating cholesterol. J Endocrinol (2016) 0.75

Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases. Front Cardiovasc Med (2017) 0.75

Oral Administration of the Endocannabinoid Anandamide during Lactation: Effects on Hypothalamic Cannabinoid Type 1 Receptor and Food Intake in Adult Mice. J Nutr Metab (2017) 0.75

Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol (2017) 0.75

Growth hormone, luteinizing hormone, and follicle-stimulating hormone regulation by neuropeptide Y in both sexes of the cichlid fish, Cichlasoma dimerus. Fish Physiol Biochem (2015) 0.75

Modulation of appetite, lipid and glucose metabolism of juvenile grass carp (Ctenopharyngodon idellus) by different dietary protein levels. Fish Physiol Biochem (2016) 0.75

Articles by these authors

The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 1.73

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53

Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet (2003) 1.47

Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) (2012) 1.33

Acromegaly. Pituitary (2006) 1.26

Isolated corticotrophin deficiency. Pituitary (2006) 1.11

Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab (2002) 1.11

Caution during use of desmopressin in IPSS. J Neurointerv Surg (2012) 1.07

Hypopituitarism. Pituitary (2006) 1.06

Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab (2003) 1.03

Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY) (2012) 1.01

Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab (2007) 0.99

The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Biotechnol Adv (2011) 0.98

Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab (2003) 0.98

Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95

Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol (2003) 0.93

Potential role for retinoic acid in patients with Cushing's disease. J Clin Endocrinol Metab (2012) 0.92

Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf) (2007) 0.92

Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol (2014) 0.90

Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin Endocrinol (Oxf) (2006) 0.90

Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) (2012) 0.89

Elastosonographic evaluation of thyroid nodules in acromegaly. Eur J Endocrinol (2009) 0.89

ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry. Endocr Pathol (2012) 0.88

Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol (2011) 0.87

Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf) (2006) 0.86

Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease. Br J Clin Pharmacol (2011) 0.85

Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab (2009) 0.85

Meningioma presenting with Cushing's syndrome: an unusual clinical presentation. Ann Neurol (2003) 0.84

High prevalence of prolonged QT interval in obese hypogonadal males. Obesity (Silver Spring) (2011) 0.83

Drugs and HPA axis. Pituitary (2008) 0.83

The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. Eur J Endocrinol (2010) 0.82

Cushing's disease. Pituitary (2006) 0.81

The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol (2009) 0.81

Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report. Endocr J (2010) 0.81

Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites. Clin Endocrinol (Oxf) (2008) 0.80

Lymphocytes and immunoglobulin patterns across the threshold of severe obesity. Endocrine (2013) 0.80

Immunomodulatory effects of VEGF: Clinical implications of VEGF-targeted therapy in human cancer. Cancer Biol Ther (2010) 0.80

Gender-dependent changes in haematological parameters in patients with Cushing's disease before and after remission. Eur J Endocrinol (2014) 0.79

Pericardial effusion requiring pericardiocentesis in a girl with anorexia nervosa. Int J Eat Disord (2006) 0.79

Carney's complex with acromegaly as the leading clinical condition. Clin Endocrinol (Oxf) (2007) 0.78

Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity. Eur J Endocrinol (2003) 0.78

Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease. Clin Exp Pharmacol Physiol (2013) 0.77

Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome. J Clin Endocrinol Metab (2015) 0.77

A new therapeutic strategy against cancer: cAMP elevating drugs and leptin. Cancer Biol Ther (2009) 0.77

Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease. Eur J Endocrinol (2007) 0.77

Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.77

Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy. Clin Endocrinol (Oxf) (2012) 0.77

AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors. Pituitary (2014) 0.76

Low insulin-like growth factor I and leukopenia in anorexia nervosa. Int J Eat Disord (2008) 0.75

Advances in the medical management of Cushing's syndrome. Expert Opin Pharmacother (2008) 0.75

Potential role of type I interferons in the treatment of pituitary adenomas. Rev Endocr Metab Disord (2008) 0.75

Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory. Pituitary (2009) 0.75

Cushing's disease and pregnancy. Pituitary (2004) 0.75